
An investigation was announced for investors, who SOLD any Allergan, Inc. (NYSE:AGN) shares between February 25, 2014 and April 21, 2014, concerning potential Securities Laws violations for having sold their AGN shares between February and April 2014 at a potentially depressed stock price.